Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.73 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.67 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.67 |
| ▸ | BCL2 | P10415 | 1/20 | 0.67 |
| ▸ | PPARG | P37231 | 3/20 | 0.65 |
| ▸ | ACE | P12821 | 2/20 | 0.65 |
| ▸ | PPARA | Q07869 | 2/20 | 0.63 |
| ▸ | YAP1 | P46937 | 1/20 | 0.62 |
| ▸ | MME | P08473 | 1/20 | 0.61 |
| ▸ | CPA1 | P15085 | 1/20 | 0.61 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.61 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.59 |
| ▸ | CTSS | P25774 | 2/20 | 0.58 |
| ▸ | CTSL | P07711 | 1/20 | 0.58 |
| ▸ | CTSB | P07858 | 1/20 | 0.58 |
| ▸ | CTSK | P43235 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2891538 | 1.00 | PTPN1 (0.73) | PTPN1ITGB3ITGA2BBCL2PPARG | |
| SCHEMBL193474 | 1.00 | PTPN1 (0.73) | PTPN1ITGB3ITGA2BBCL2PPARG | |
| SCHEMBL28267499 | 0.95 | PTPN1 (0.77) | PTPN1ITGB3ITGA2BBCL2PPARG | |
| SCHEMBL28267496 | 0.95 | PTPN1 (0.77) | PTPN1ITGB3ITGA2BBCL2PPARG | |
| SCHEMBL464744 | 0.93 | PTPN1 (0.65) | PTPN1ITGB3ITGA2BBCL2PPARG | |
| Phenylalanine Methyl Ester SCHEMBL28119144 | 0.91 | PTPN1 (0.63) | PTPN1ITGB3ITGA2BBCL2PPARG | |
| SCHEMBL3350988 | 0.91 | BCL2 (0.64) | PTPN1ITGB3ITGA2BBCL2PPARG | |
| SCHEMBL9752771 | 0.91 | BCL2 (0.64) | PTPN1ITGB3ITGA2BBCL2PPARG | |
| SCHEMBL9752770 | 0.91 | BCL2 (0.64) | PTPN1ITGB3ITGA2BBCL2PPARG | |
| SCHEMBL3500186 | 0.91 | BCL2 (0.64) | PTPN1ITGB3ITGA2BBCL2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119161409-A | ((S) -2-amino-3- (4- (benzyloxy) phenyl) propionyl) -L-leucine benzyl ester hydrochloride, and preparation method and application thereof | 成都普康唯新生物科技有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-111825742-B | Polypeptide solid phase synthesis of CTPA as special coupling agent for amino acid ionic liquid | 陈铭 | 2024-01-30 | — | — | CN | claimed |
| CN-106188231-B | Synthesis and application of pasireotide pentapeptide intermediate | 中国医学科学院药物研究所 | 2021-10-22 | — | — | CN | claimed |
| CN-106188231-A | The synthesis of pasireotide pentapeptide intermediate and application | 中国医学科学院药物研究所 | 2016-12-07 | — | — | CN | claimed |
| US-4033998-A | Vinylbenzyl ester of an N-BOC amino acid | MORTON-NORWICH PRODUCTS, INC. (US) | 1977-07-05 | — | — | US | claimed |
| US-12625431-B2 | EUV resist underlayer film-forming composition | NISSAN CHEMICAL CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20260071353-A1 | SUBSTRATES, PEPTIDE ARRAYS, AND METHODS | VIBRANT HOLDINGS LLC (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4638415-A1 | BIS-ESTER AND AMIDE CATIONIC LIPIDS | Sanofi Pasteur Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-12454771-B2 | Substrates, peptide arrays, and methods | VIBRANT HOLDINGS LLC (US) | 2025-10-28 | — | — | US | disclosed |
| CN-120051461-A | VHH antibody conjugates | 雅博得乐医疗公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119161409-A | ((S) -2-amino-3- (4- (benzyloxy) phenyl) propionyl) -L-leucine benzyl ester hydrochloride, and preparation method and application thereof | 成都普康唯新生物科技有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-115053184-B | Composition for forming EUV resist underlayer film | 日产化学株式会社 | 2024-12-06 | — | — | CN | disclosed |
| US-4082736-A | NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF | SYNTEX (U.S.A.) INC. (US) | 1978-04-04 | — | — | US | disclosed |
| US-4062815-A | DIVINYLBENZENE CROSSLINKED POLYSTYRENE | ARMOUR PHARMACEUTICAL COMPANY (US) | 1977-12-13 | — | — | US | disclosed |
| US-4060689-A | Vinylbenzyl esters of n-boc-amino acids | MORTON-NORWICH PRODUCTS, INC. (US) | 1977-11-29 | — | — | US | disclosed |
| US-4051171-A | Vinylbenzyl esters of N-BOC-amino acids | MORTON-NORWICH PRODUCTS, INC. (US) | 1977-09-27 | — | — | US | disclosed |
| US-4033998-A | Vinylbenzyl ester of an N-BOC amino acid | MORTON-NORWICH PRODUCTS, INC. (US) | 1977-07-05 | — | — | US | disclosed |
| US-4033940-A | TERMINAL CYSTINE, REARRANGEMENT TO CYCLIC DISULFIDE | ARMOUR PHARMACEUTICAL COMPANY (US) | 1977-07-05 | — | — | US | disclosed |
| US-3974135-A | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for producing the same | FOLKERS KARL | 1976-08-10 | — | — | US | disclosed |
| US-3953416-A | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for manufacturing the same | FOLKERS KARL | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071353-A1 | SUBSTRATES, PEPTIDE ARRAYS, AND METHODS | VIP, CALCB, SPPL2B | PTPN1 1568/4885ITGB3 413/4885ITGA2B 229/4885 |
| US-12625431-B2 | EUV resist underlayer film-forming composition | EEF1A1, ARF1, EMG1 | PTPN1 912/4885ITGB3 358/4885ITGA2B 496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.